Results 201 to 210 of about 1,416,698 (318)

Enzymatic and non-enzymatic oxidation of fibrillar collagen. [PDF]

Redox Rep
Mathias-Netto FC, Cantuária NM, Gaspar RS.   +2 more
europepmc   +1 more source

Unraveling 4‐Phenylbutyrate's Therapeutic Role in SLC6A1 Disorders: Pharmacochaperoning Over HDAC Inhibition

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw, Karishma Randhave, Ekta Anand, Ziang (Debbie) Song, Wangzhen Shen, Jing‐Qiong Kang   +5 more
wiley   +1 more source

Unraveling the Superior High-Temperature Oxidation Behavior of FeNiCuAl-Based High-Entropy Alloys: Roles of Cr, Co, and Mn Alloying Additions. [PDF]

Materials (Basel)
Ren K, Gao X, Yang R, Fu J.
europepmc   +1 more source

Plasma EV Proteomics Identifies ECM Remodeling and Inflammatory Proteins LUM and C7 as Candidate Biomarkers in FSHD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...
Mustafa Bilal Bayazit, Chiranth K. Nagaraj, Jackson S. Newell, Kim Truc Nguyen, Xilal Y. Rima, Jacob Doon‐Ralls, Eduardo Reátegui, Jeffrey M. Statland, Rabi Tawil, Kevin M. Flanigan, Scott Q. Harper, Nizar Y. Saad   +11 more
wiley   +1 more source

Deep Removal and Photodegradation of Methylene Blue Dye Using Superabsorbent Polymer Hydrogel Composite with Activated Charcoal and TiO2 Nanoparticles

ACS Omega
Syed Sikandar Shah, Bruno Ramos, Larissa Otubo, Antonio Carlos Silva Costa Teixeira   +3 more
doaj   +1 more source

The microbial nexus: linking arsenic biogeochemistry with greenhouse gas emissions. [PDF]

Front Microbiol
Wu Z, Li M, Liu C, Luo R, Song T, Zhang P, Wang Y, Li P.   +7 more
europepmc   +1 more source

Oxidative eustress: the physiological role of oxidants

Science China Life Sciences, 2023
openaire   +2 more sources

Effects of Add‐On Icosapent Ethyl With Standard Treatment on Functional Outcomes and Inflammatory Biomarkers in Acute Ischemic Stroke: A Blinded Randomized Controlled Trial

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Ischemic stroke, a major cause of mortality and long‐term disability, results from the abrupt cessation of cerebral blood flow due to vascular occlusion or rupture. Icosapent Ethyl (EPA‐EE), approved for hypertriglyceridemia, has anti‐inflammatory and antithrombotic properties that may lessen ischemic damage.
Mitra Mahmoudi Meymand, Seyed Hossein Aghamiri, Saeed Mohmammad Soleymani, Shadiyeh Bararpoor Poshkohi, Samaneh Masoudi, Hadi Esmaily   +5 more
wiley   +1 more source

Research Progress and Prospects of Ultra-High-Temperature Ceramics: Experimentation, Multiscale Simulation and Data-Driven Design. [PDF]

Nanomaterials (Basel)
Qu N, Zhou W, Zhang W, Liu Y, Zheng L, Cao D, Tan M, Zhu J, Zhang X.   +8 more
europepmc   +1 more source

A 57‐Year‐Old Male With Behavioral Variant Frontotemporal Dementia and MATR3 and NOS3 Mutations

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT This report presents a case of behavioral variant frontotemporal dementia caused by mutations in the MATR3 and NOS3 genes, aiming to analyze its clinical manifestations and genetic characteristics. For a case presenting with personality changes and gait abnormalities as the initial symptoms, this study conducted a comprehensive analysis of its
Feifei Lin, Saie Huang
wiley   +1 more source